AmplifEYE Colonoscopy vs Standard Colonoscopy

Status Completed

Clinical Trial Summary

Colonoscopy screening is proven to reduce mortality rates for colorectal cancer, which relies on early detection and removal of colonic polyps. AmplifEYE is a FDA-approved device with a row of flexible detection arms attached to the tip of colonoscope which can separate colonic folds during scope withdrawal and is believed to improve polyp detection. Real-life clinical data on this relatively new device is lacking and this study aims to compare the adenoma and polyp detection rates in AmplifEYE-assisted colonoscopy versus standard colonoscopy.

Clinical Trial Description

This is a prospective, randomized controlled study. Patients admitted to Queen Elizabeth Hospital and Our Lady of Maryknoll Hospital for colonoscopy are randomly allocated 1:1 to receive either colonoscopy equipped with AmplifEYE (AC) or standard colonoscopy (SC). All study team members will have a prior run-in phase of performing at least 5 AmplifEYE colonoscopies before starting the study. The colonic polyp detection rate (PDR), adenoma detection rate (ADR), serrated polyp detection rate (SDR), caecal intubation time, colonoscope withdrawal time, procedure pain and any adverse events were analyzed in each group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03814369
Study type	Interventional
Source	Queen Elizabeth Hospital, Hong Kong
Contact
Status	Completed
Phase	N/A
Start date	March 1, 2017
Completion date	November 30, 2018

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03746353` - Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer	N/A
Recruiting	`NCT05809999` - IBD Neoplasia Surveillance RCT	N/A
Recruiting	`NCT06041945` - Artificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp Histology	N/A
Not yet recruiting	`NCT02688699` - Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract	Phase 4
Not yet recruiting	`NCT03175146` - A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely	N/A
Completed	`NCT02529007` - Endo-cuff Assisted Vs. Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening	N/A
Not yet recruiting	`NCT01929499` - Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer	Phase 2
Completed	`NCT01681472` - PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer	Phase 1/Phase 2
Completed	`NCT01438645` - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy	N/A
Completed	`NCT00535652` - Concentration of Ertapenem in Colorectal Tissue	Phase 4
Terminated	`NCT00267787` - Molecular Genetic and Pathological Studies of Anal Tumors
Completed	`NCT05498051` - Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.	N/A
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT03314896` - Laparoscopic Surgery for T4 Tumor of the Colon Cancer (LST4C Trial)	N/A
Not yet recruiting	`NCT02852915` - Laparoscopic Surgery for T4 Tumor of the Colon Cancer	Phase 3
Not yet recruiting	`NCT02777437` - Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer	Phase 2/Phase 3
Completed	`NCT00997802` - Japanese National Computed Tomographic (CT) Colonography Trial	N/A
Completed	`NCT01056913` - NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery	Phase 4
Completed	`NCT00537901` - First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study	N/A
Completed	`NCT00470782` - Aerobic Capacity and Body Composition in Colon Cancer Patients	N/A